Peptide Compound Index by Category

Healing & Recovery

11

BPC-157Preclinical only
Studied for tendon and gut tissue repair — animal models only
KLOW blendNot approved
KPV, GHK-Cu, BPC-157 and TB-500 in one vial — never tested as a blend
KPVPreclinical only
Studied for gut inflammation — animal and cell models only
LarazotidePhase 3 stopped by sponsor
Tested as a coeliac disease add-on — mixed symptom results; Phase 3 terminated in 2022
LL-37Early clinical
Antimicrobial peptide studied for wound healing — early trials
Superhuman stack
TB-500Preclinical only
Thymosin β4 fragment; studied for tissue repair — no human trials
Thymosin
Thymosin Alpha-1Approved outside US
Immune modulator approved in some countries, not the US
VIPNot approved · research probe
Hormone made in nerves — human data is mostly measured levels and single research infusions
Wolverine stackNot approved
BPC-157 and TB-500 used together — the pair has not been studied in people

10

AOD-9604Trials discontinued
hGH fragment tested for fat loss — trials did not lead to approval
BAM15Preclinical only
Mitochondrial uncoupler sold as a peptide — fat and glucose results in mice only
C-peptideLab measurement
Marker of the pancreas's own insulin output — measured, not taken
GLP-1Endogenous hormone
Gut hormone behind semaglutide, tirzepatide and similar drugs
GLP-3No compound by this name
A search name — points to GLP-2 imitations and the triple agonist retatrutide
LiraglutideFDA approved
Daily GLP-1 drug approved for type 2 diabetes and weight management
Natriuretic peptideLab measurement
Heart-strain blood marker — measured on a lab report, not taken
RetatrutidePhase 3 · not FDA approved
Triple agonist in Phase 3 trials for weight loss — not approved
SemaglutideFDA approved
Weekly GLP-1 drug approved for type 2 diabetes and weight management
TirzepatideFDA approved
Weekly GIP / GLP-1 drug approved for type 2 diabetes and weight management

9

CJC-1295Trials discontinued
Raises growth hormone; development stopped after early trials
FollistatinNot approved
Myostatin blocker studied mostly as gene therapy in animals — one human study
Hexarelin
HGHFDA approved · prescription
Prescription growth hormone; non-medical use has documented risks
IGF-1FDA approved as mecasermin
Growth factor approved as mecasermin for rare growth disorders
IpamorelinTrials discontinued
Growth-hormone releaser; trials stopped before approval
MK-677Not approved
Oral growth hormone secretagogue — randomised human trials from 1996 to 2011
SermorelinFormerly FDA approved
Growth-hormone releaser; US brand discontinued
TesamorelinFDA approved
Approved to reduce abdominal fat in HIV lipodystrophy

5

CerebrolysinApproved outside the US · not FDA-approved
Pig-brain peptide infusion trialled in stroke, brain injury and dementia — reviews split on benefit
DihexaPreclinical only
Studied for memory loss in Alzheimer's models — animal and cell work only; key paper retracted
DSIPEarly clinical · not FDA approved
Studied for sleep in small, older trials — findings inconsistent
SelankNot FDA approved
Studied for anxiety — mostly small Russian studies
SemaxNot FDA approved
Studied for cognition and stroke recovery — mostly Russian studies

6

EpitalonPreclinical · early human reports
Studied for ageing and telomeres — mostly rodents, flies and cells, largely from one Russian group
GlutathioneDietary supplement
Antioxidant tripeptide sold as a supplement; limited trial data
MOTS-cPreclinical only
Studied for metabolism and exercise capacity — animal models only
NAD+Not a peptide
Coenzyme marketed for ageing — not a peptide
PNC-27Preclinical only
Studied for killing cancer cells — cell lines and mice only, never tested in people
SS-31FDA approved · limited indication
Mitochondria-targeted; studied mainly in rare mitochondrial disease

8

ArgirelineCosmetic ingredient
Sold as a topical Botox alternative — small, short human trials, one negative
CollagenDietary supplement
Oral supplement studied for skin and joints — mixed human data
Copper PeptidesCosmetic ingredient
Used in skincare; human data mostly topical and small
GHK-CuCosmetic ingredient
Copper peptide used in skincare; injected use largely unstudied
GLOW blendNot approved
GHK-Cu, BPC-157 and TB-500 in one vial — never tested as a blend
MatrixylCosmetic ingredient
Anti-wrinkle cream peptide — fewer fine lines in one 93-woman trial; collagen data from cells
MelanotanMT-II not FDA approved
Tanning peptides; MT-I approved for a rare condition, MT-II not
SNAP-8Cosmetic ingredient
Sold for expression lines — no study of SNAP-8 itself; the evidence is for argireline

3

HCGPrescription medicine
Pregnancy hormone with a fertility-care trial record — no weight-loss trial behind the page
KisspeptinEarly clinical
Studied in fertility and hormone research — early human trials
PT-141FDA approved
Approved for low sexual desire in premenopausal women